Tapewire

Nasdaq · USD

VIR

Vir Biotechnology, Inc.

Export transactions ↓
Tapewire entity
4522
SEC CIK
0001706431
Parsed reports
486

Last 12 months

Inside the activity.

0 purchase rows · 35 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202508
Dec 202502
Jan 202601
Feb 2026016
Mar 202603
Apr 202602
May 202601
Jun 202602
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
August 11, 2026 Filed Aug 12, 2026 18:30 UTC OtherCommon Stock 8,000 $0.00 $0.00
Disclosure

SEC source: 0001628280-26-056108 · wk-form4_1786559443.xml · nonDerivative · entry 2

MORE ROBERT J · CIK 0001207792 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 517,917

F1 · kind: Shares held by the Reporting Person for the benefit of Alta Partners NextGen Fund I, L.P. (APNG 1) were transferred by the Reporting Person for no consideration to APNG 1 in connection with the vesting of restricted stock unit (RSU) awards.

F2 · ownership.nature: The shares are held by APNG 1. The Reporting Person is a managing director of Alta Partners NextGen Fund I Management, LLC, which is the general partner of APNG I. As such, the Reporting Person may be deemed to beneficially own the shares held by APNG 1; however, the Reporting Person disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein, and this report shall not be deemed to be an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise.

Read SEC document
August 11, 2026 Filed Aug 12, 2026 18:30 UTC OtherCommon Stock 8,000 $0.00 $0.00
Disclosure

SEC source: 0001628280-26-056108 · wk-form4_1786559443.xml · nonDerivative · entry 1

MORE ROBERT J · CIK 0001207792 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,656

F1 · kind: Shares held by the Reporting Person for the benefit of Alta Partners NextGen Fund I, L.P. (APNG 1) were transferred by the Reporting Person for no consideration to APNG 1 in connection with the vesting of restricted stock unit (RSU) awards.

Read SEC document
June 09, 2026 Filed Jun 10, 2026 22:21 UTC GrantStock Option (Right to Buy) · Derivative 16,000 $0.00 Strike: $8.51 $0.00
Disclosure

SEC source: 0001628280-26-042326 · wk-form4_1781130089.xml · derivative · entry 4

Coughlin Timothy · CIK 0001376043 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,000

Underlying: Common Stock · 16,000 shares

Expires 2036-06-08

F5 · derivative.exercise_date: The shares subject to the stock option vest and become exercisable in full on the earlier of (i) June 9, 2027, or (ii) the date of the Issuer's next annual meeting of stockholders.

Read SEC document
June 09, 2026 Filed Jun 10, 2026 22:21 UTC GrantStock Option (Right to Buy) · Derivative 16,000 $0.00 Strike: $8.51 $0.00
Disclosure

SEC source: 0001628280-26-042326 · wk-form4_1781130089.xml · derivative · entry 3

Coughlin Timothy · CIK 0001376043 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,000

Underlying: Common Stock · 16,000 shares

Expires 2036-06-08

F4 · derivative.exercise_date: 1/3 of the shares subject to the stock option will vest and become exercisable on June 9, 2027, and the remaining shares will vest and become exercisable in 24 equal monthly installments thereafter.

Read SEC document
June 09, 2026 Filed Jun 10, 2026 22:21 UTC GrantCommon Stock 8,000 $0.00 $0.00
Disclosure

SEC source: 0001628280-26-042326 · wk-form4_1781130089.xml · nonDerivative · entry 2

Coughlin Timothy · CIK 0001376043 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,000

F1 · kind: Acquisition of restricted stock units (RSUs) pursuant to the Issuer's Equity Incentive Plan.

F3 · shares: The RSUs will vest in full on the earlier of (i) June 9, 2027, or (ii) the date of the Issuer's next annual meeting of stockholders.

Read SEC document
June 09, 2026 Filed Jun 10, 2026 22:21 UTC GrantCommon Stock 8,000 $0.00 $0.00
Disclosure

SEC source: 0001628280-26-042326 · wk-form4_1781130089.xml · nonDerivative · entry 1

Coughlin Timothy · CIK 0001376043 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,000

F1 · kind: Acquisition of restricted stock units (RSUs) pursuant to the Issuer's Equity Incentive Plan.

F2 · shares: 1/3 of the RSUs will vest on June 9, 2027, and the remaining RSUs will vest in two equal annual installments thereafter.

Read SEC document
June 01, 2026 Filed Jun 2, 2026 21:31 UTC
Sabatini BrentSVP, Chief Accounting Officer
SaleCommon Stock 379 $9.45 $3,581.55
Disclosure

SEC source: 0001628280-26-039938 · wk-form4_1780435911.xml · nonDerivative · entry 1

Sabatini Brent · CIK 0002037272 · SVP, Chief Accounting Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 61,902

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 19, 2025.

F2 · balance_after: Includes 379 shares of common stock acquired by the Reporting Person on May 29, 2026 pursuant to an employee stock purchase program.

Read SEC document
June 01, 2026 Filed Jun 2, 2026 21:35 UTC SaleCommon Stock 3,200 $9.45 $30,240.00
Disclosure

SEC source: 0001628280-26-039943 · wk-form4_1780436119.xml · nonDerivative · entry 1

Napolitano Janet · CIK 0001821008 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 21,216

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 27, 2025.

Read SEC document
May 27, 2026 Filed May 28, 2026 23:25 UTC GrantStock Option (Right to Buy) · Derivative 16,000 $0.00 Strike: $9.10 $0.00
Disclosure

SEC source: 0001628280-26-038966 · wk-form4_1780010743.xml · derivative · entry 3

Sigal Charles Elliott · CIK 0001661908 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,000

Underlying: Common Stock · 16,000 shares

Expires 2036-05-26

F4 · shares: The shares subject to the stock option will vest and become exercisable in full on May 27, 2027.

Read SEC document
May 27, 2026 Filed May 28, 2026 23:25 UTC GrantCommon Stock 8,000 $0.00 $0.00
Disclosure

SEC source: 0001628280-26-038966 · wk-form4_1780010743.xml · nonDerivative · entry 1

Sigal Charles Elliott · CIK 0001661908 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 39,806

F1 · kind: Acquisition of restricted stock units (RSUs) pursuant to the Issuer's Equity Incentive Plan.

F2 · shares: The RSUs will vest in full on May 27, 2027.

Read SEC document
May 27, 2026 Filed May 28, 2026 23:25 UTC GrantStock Option (Right to Buy) · Derivative 16,000 $0.00 Strike: $9.10 $0.00
Disclosure

SEC source: 0001628280-26-038965 · wk-form4_1780010721.xml · derivative · entry 2

Napolitano Janet · CIK 0001821008 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,000

Underlying: Common Stock · 16,000 shares

Expires 2036-05-26

F3 · shares: The shares subject to the stock option will vest and become exercisable in full on May 27, 2027.

Read SEC document
May 27, 2026 Filed May 28, 2026 23:25 UTC GrantCommon Stock 8,000 $0.00 $0.00
Disclosure

SEC source: 0001628280-26-038965 · wk-form4_1780010721.xml · nonDerivative · entry 1

Napolitano Janet · CIK 0001821008 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,416

F1 · kind: Acquisition of restricted stock units (RSUs) pursuant to the Issuer's Equity Incentive Plan.

F2 · shares: The RSUs will vest in full on May 27, 2027.

Read SEC document
May 27, 2026 Filed May 28, 2026 23:24 UTC GrantStock Option (Right to Buy) · Derivative 16,000 $0.00 Strike: $9.10 $0.00
Disclosure

SEC source: 0001628280-26-038963 · wk-form4_1780010671.xml · derivative · entry 2

Hatfield Jeffrey S. · CIK 0001609879 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,000

Underlying: Common Stock · 16,000 shares

Expires 2036-05-26

F3 · shares: The shares subject to the stock option will vest and become exercisable in full on May 27, 2027.

Read SEC document
May 27, 2026 Filed May 28, 2026 23:24 UTC GrantCommon Stock 8,000 $0.00 $0.00
Disclosure

SEC source: 0001628280-26-038963 · wk-form4_1780010671.xml · nonDerivative · entry 1

Hatfield Jeffrey S. · CIK 0001609879 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 39,806

F1 · kind: Acquisition of restricted stock units (RSUs) pursuant to the Issuer's Equity Incentive Plan.

F2 · shares: The RSUs will vest in full on May 27, 2027.

Read SEC document
May 27, 2026 Filed May 28, 2026 23:25 UTC GrantStock Option (Right to Buy) · Derivative 16,000 $0.00 Strike: $9.10 $0.00
Disclosure

SEC source: 0001628280-26-038964 · wk-form4_1780010697.xml · derivative · entry 3

MORE ROBERT J · CIK 0001207792 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,000

Underlying: Common Stock · 16,000 shares

Expires 2036-05-26

F4 · shares: The shares subject to the stock option will vest and become exercisable in full on May 27, 2027.

Read SEC document
May 27, 2026 Filed May 28, 2026 23:25 UTC GrantCommon Stock 8,000 $0.00 $0.00
Disclosure

SEC source: 0001628280-26-038964 · wk-form4_1780010697.xml · nonDerivative · entry 1

MORE ROBERT J · CIK 0001207792 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 48,656

F1 · kind: Acquisition of restricted stock units (RSUs) pursuant to the Issuer's Equity Incentive Plan.

F2 · shares: The RSUs will vest in full on May 27, 2027.

Read SEC document
May 27, 2026 Filed May 28, 2026 23:24 UTC
Farid RamyDirector
GrantStock Option (Right to Buy) · Derivative 16,000 $0.00 Strike: $9.10 $0.00
Disclosure

SEC source: 0001628280-26-038962 · wk-form4_1780010645.xml · derivative · entry 2

Farid Ramy · CIK 0001797707 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,000

Underlying: Common Stock · 16,000 shares

Expires 2036-05-26

F3 · shares: The shares subject to the stock option will vest and become exercisable in full on May 27, 2027.

Read SEC document
May 27, 2026 Filed May 28, 2026 23:24 UTC
Farid RamyDirector
GrantCommon Stock 8,000 $0.00 $0.00
Disclosure

SEC source: 0001628280-26-038962 · wk-form4_1780010645.xml · nonDerivative · entry 1

Farid Ramy · CIK 0001797707 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 32,000

F1 · kind: Acquisition of restricted stock units (RSUs) pursuant to the Issuer's Equity Incentive Plan.

F2 · shares: The RSUs will vest in full on May 27, 2027.

Read SEC document
May 27, 2026 Filed May 28, 2026 23:23 UTC GrantStock Option (Right to Buy) · Derivative 16,000 $0.00 Strike: $9.10 $0.00
Disclosure

SEC source: 0001628280-26-038961 · wk-form4_1780010616.xml · derivative · entry 3

BISCHOFBERGER NORBERT W · CIK 0001190273 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,000

Underlying: Common Stock · 16,000 shares

Expires 2036-05-26

F4 · shares: The shares subject to the stock option will vest and become exercisable in full on May 27, 2027.

Read SEC document
May 27, 2026 Filed May 28, 2026 23:23 UTC GrantCommon Stock 8,000 $0.00 $0.00
Disclosure

SEC source: 0001628280-26-038961 · wk-form4_1780010616.xml · nonDerivative · entry 1

BISCHOFBERGER NORBERT W · CIK 0001190273 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,333

F1 · kind: Acquisition of restricted stock units (RSUs) pursuant to the Issuer's Equity Incentive Plan.

F2 · shares: The RSUs will vest in full on May 27, 2027.

Read SEC document
May 01, 2026 Filed May 4, 2026 16:35 UTC
SATO VICKI LDirector
SaleCommon Stock 22,000 $10.05 $221,025.20
Disclosure

SEC source: 0001628280-26-029640 · wk-form4_1777912538.xml · nonDerivative · entry 1

SATO VICKI L · CIK 0001197020 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,078,391

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 27, 2025.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.94 to $10.23, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

Read SEC document
April 29, 2026 Filed Apr 30, 2026 21:43 UTC
De Backer MarianneDirector · President and CEO
OtherCommon Stock 233,532 $0.00 $0.00
Disclosure

SEC source: 0001628280-26-029041 · wk-form4_1777585398.xml · nonDerivative · entry 2

De Backer Marianne · CIK 0001797819 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 286,650

F1 · kind: Transfer without consideration for tax and estate planning purposes.

F2 · ownership.nature: The shares are held in the name of the Ureel-De Backer Family Trust, of which the Reporting Person and her spouse are Trustees.

Read SEC document
April 29, 2026 Filed Apr 30, 2026 21:43 UTC
De Backer MarianneDirector · President and CEO
OtherCommon Stock 233,532 $0.00 $0.00
Disclosure

SEC source: 0001628280-26-029041 · wk-form4_1777585398.xml · nonDerivative · entry 1

De Backer Marianne · CIK 0001797819 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 714,613

F1 · kind: Transfer without consideration for tax and estate planning purposes.

Read SEC document
April 06, 2026 Filed Apr 7, 2026 20:50 UTC
De Backer MarianneDirector · President and CEO
SaleCommon Stock 72,559 $9.16 $664,350.20
Disclosure

SEC source: 0001628280-26-024098 · wk-form4_1775595054.xml · nonDerivative · entry 1

De Backer Marianne · CIK 0001797819 · Director · President and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 948,145

F1 · kind: Represents an automatic and mandatory sale of shares under a Rule 10b5-1 arrangement to satisfy the Issuer's tax withholding obligations in connection with the vesting of restricted stock units. The sale does not represent a discretionary trade by the Reporting Person.

Read SEC document
April 01, 2026 Filed Apr 2, 2026 14:46 UTC
SATO VICKI LDirector
SaleCommon Stock 22,000 $9.07 $199,617.00
Disclosure

SEC source: 0001628280-26-022971 · wk-form4_1775141198.xml · nonDerivative · entry 1

SATO VICKI L · CIK 0001197020 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,100,391

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 27, 2025.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.87 to $9.20, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

Read SEC document
March 23, 2026 Filed Mar 24, 2026 20:35 UTC
Sabatini BrentSVP, Chief Accounting Officer
SaleCommon Stock 7,711 $9.12 $70,324.32
Disclosure

SEC source: 0001628280-26-020823 · wk-form4_1774384534.xml · nonDerivative · entry 1

Sabatini Brent · CIK 0002037272 · SVP, Chief Accounting Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 61,902

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 19, 2025.

Read SEC document
March 20, 2026 Filed Mar 23, 2026 19:49 UTC
O'Byrne JasonEVP & Chief Financial Officer
OtherCommon Stock 2,500 $0.00 $0.00
Disclosure

SEC source: 0001628280-26-020480 · wk-form4_1774295389.xml · nonDerivative · entry 2

O'Byrne Jason · CIK 0001871145 · EVP & Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 2,500

F1 · kind: Transfer without consideration for estate planning purposes.

F2 · ownership.nature: The shares are held in the name of the O'Byrne Family Trust, of which the Reporting Person and his spouse are Trustees.

Read SEC document
March 20, 2026 Filed Mar 23, 2026 19:49 UTC
O'Byrne JasonEVP & Chief Financial Officer
OtherCommon Stock 2,500 $0.00 $0.00
Disclosure

SEC source: 0001628280-26-020480 · wk-form4_1774295389.xml · nonDerivative · entry 1

O'Byrne Jason · CIK 0001871145 · EVP & Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 160,115

F1 · kind: Transfer without consideration for estate planning purposes.

Read SEC document
March 02, 2026 Filed Mar 3, 2026 17:10 UTC
SATO VICKI LDirector
SaleCommon Stock 200 $9.98 $1,996.00
Disclosure

SEC source: 0001628280-26-013630 · wk-form4_1772557800.xml · nonDerivative · entry 2

SATO VICKI L · CIK 0001197020 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,122,391

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 27, 2025.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.97 to $9.99, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

Read SEC document
March 02, 2026 Filed Mar 3, 2026 17:10 UTC
SATO VICKI LDirector
SaleCommon Stock 21,800 $9.50 $207,185.02
Disclosure

SEC source: 0001628280-26-013630 · wk-form4_1772557800.xml · nonDerivative · entry 1

SATO VICKI L · CIK 0001197020 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,122,591

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 27, 2025.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.97 to $9.91, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

Read SEC document
February 25, 2026 Filed Feb 26, 2026 21:55 UTC
Eisner MarkEVP and Chief Medical Officer
SaleCommon Stock 1,889 $9.82 $18,549.98
Disclosure

SEC source: 0001628280-26-012394 · wk-form4_1772142916.xml · nonDerivative · entry 2

Eisner Mark · CIK 0001834161 · EVP and Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 154,024

F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 19, 2025.

Read SEC document
February 25, 2026 Filed Feb 26, 2026 21:54 UTC
de Verneuil VaninaEVP, General Counsel, Corp Sec
SaleCommon Stock 13,700 $9.82 $134,534.00
Disclosure

SEC source: 0001628280-26-012393 · wk-form4_1772142894.xml · nonDerivative · entry 2

de Verneuil Vanina · CIK 0002036234 · EVP, General Counsel, Corp Sec

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 112,982

F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 2, 2025.

Read SEC document
February 24, 2026 Filed Feb 26, 2026 21:56 UTC
Sabatini BrentSVP, Chief Accounting Officer
SaleCommon Stock 1,430 $9.53 $13,631.62
Disclosure

SEC source: 0001628280-26-012396 · wk-form4_1772142963.xml · nonDerivative · entry 1

Sabatini Brent · CIK 0002037272 · SVP, Chief Accounting Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 69,613

F1 · kind: Represents an automatic and mandatory sale of shares under a Rule 10b5-1 arrangement to satisfy the Issuer's tax withholding obligations in connection with the vesting of restricted stock units. The sale does not represent a discretionary trade by the Reporting Person.

Read SEC document
February 24, 2026 Filed Feb 26, 2026 21:56 UTC
SATO VICKI LDirector
Exercise / conversionStock Option (Right to Buy) · Derivative 42,377 $0.00 Strike: $1.49 $0.00
Disclosure

SEC source: 0001628280-26-012397 · wk-form4_1772142986.xml · derivative · entry 4

SATO VICKI L · CIK 0001197020 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 42,377 shares

Expires 2027-10-05

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: Shares vested and became exercisable in 36 equal monthly installments from October 5, 2017.

Read SEC document
February 24, 2026 Filed Feb 26, 2026 21:56 UTC
SATO VICKI LDirector
SaleCommon Stock 200 $10.26 $2,052.00
Disclosure

SEC source: 0001628280-26-012397 · wk-form4_1772142986.xml · nonDerivative · entry 3

SATO VICKI L · CIK 0001197020 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,144,391

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 27, 2025.

Read SEC document
February 24, 2026 Filed Feb 26, 2026 21:56 UTC
SATO VICKI LDirector
SaleCommon Stock 42,177 $9.75 $411,314.32
Disclosure

SEC source: 0001628280-26-012397 · wk-form4_1772142986.xml · nonDerivative · entry 2

SATO VICKI L · CIK 0001197020 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,144,591

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 27, 2025.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.23 to $10.20, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

Read SEC document
February 24, 2026 Filed Feb 26, 2026 21:56 UTC
SATO VICKI LDirector
Exercise / conversionCommon Stock 42,377 $1.49 $62,929.85
Disclosure

SEC source: 0001628280-26-012397 · wk-form4_1772142986.xml · nonDerivative · entry 1

SATO VICKI L · CIK 0001197020 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,186,768

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 24, 2026 Filed Feb 26, 2026 21:55 UTC
Eisner MarkEVP and Chief Medical Officer
SaleCommon Stock 1,616 $9.53 $15,404.68
Disclosure

SEC source: 0001628280-26-012394 · wk-form4_1772142916.xml · nonDerivative · entry 1

Eisner Mark · CIK 0001834161 · EVP and Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 155,913

F1 · kind: Represents an automatic and mandatory sale of shares under a Rule 10b5-1 arrangement to satisfy the Issuer's tax withholding obligations in connection with the vesting of restricted stock units. The sale does not represent a discretionary trade by the Reporting Person.

Read SEC document
February 24, 2026 Filed Feb 26, 2026 21:54 UTC
de Verneuil VaninaEVP, General Counsel, Corp Sec
SaleCommon Stock 3,117 $9.53 $29,713.11
Disclosure

SEC source: 0001628280-26-012393 · wk-form4_1772142894.xml · nonDerivative · entry 1

de Verneuil Vanina · CIK 0002036234 · EVP, General Counsel, Corp Sec

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 126,682

F1 · kind: Represents an automatic and mandatory sale of shares under a Rule 10b5-1 arrangement to satisfy the Issuer's tax withholding obligations in connection with the vesting of restricted stock units. The sale does not represent a discretionary trade by the Reporting Person.

Read SEC document
February 24, 2026 Filed Feb 26, 2026 21:55 UTC
O'Byrne JasonEVP & Chief Financial Officer
SaleCommon Stock 1,634 $9.53 $15,576.27
Disclosure

SEC source: 0001628280-26-012395 · wk-form4_1772142937.xml · nonDerivative · entry 1

O'Byrne Jason · CIK 0001871145 · EVP & Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 162,615

F1 · kind: Represents an automatic and mandatory sale of shares under a Rule 10b5-1 arrangement to satisfy the Issuer's tax withholding obligations in connection with the vesting of restricted stock units. The sale does not represent a discretionary trade by the Reporting Person.

Read SEC document
February 24, 2026 Filed Feb 26, 2026 21:54 UTC
De Backer MarianneDirector · Chief Executive Officer
SaleCommon Stock 14,762 $9.53 $140,720.24
Disclosure

SEC source: 0001628280-26-012390 · wk-form4_1772142870.xml · nonDerivative · entry 1

De Backer Marianne · CIK 0001797819 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,020,704

F1 · kind: Represents an automatic and mandatory sale of shares under a Rule 10b5-1 arrangement to satisfy the Issuer's tax withholding obligations in connection with the vesting of restricted stock units. The sale does not represent a discretionary trade by the Reporting Person.

Read SEC document
February 23, 2026 Filed Feb 25, 2026 00:13 UTC
Sabatini BrentSVP, Chief Accounting Officer
SaleCommon Stock 1,829 $7.45 $13,631.17
Disclosure

SEC source: 0001628280-26-011331 · wk-form4_1771978411.xml · nonDerivative · entry 2

Sabatini Brent · CIK 0002037272 · SVP, Chief Accounting Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 71,043

F2 · kind: Represents an automatic and mandatory sale of shares under a Rule 10b5-1 arrangement to satisfy the Issuer's tax withholding obligations in connection with the vesting of restricted stock units. The sale does not represent a discretionary trade by the Reporting Person.v

Read SEC document
February 23, 2026 Filed Feb 25, 2026 00:12 UTC
O'Byrne JasonEVP & Chief Financial Officer
SaleCommon Stock 2,089 $7.45 $15,568.90
Disclosure

SEC source: 0001628280-26-011330 · wk-form4_1771978342.xml · nonDerivative · entry 2

O'Byrne Jason · CIK 0001871145 · EVP & Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 164,249

F3 · kind: Represents an automatic and mandatory sale of shares under a Rule 10b5-1 arrangement to satisfy the Issuer's tax withholding obligations in connection with the vesting of RSUs. The sale does not represent a discretionary trade by the Reporting Person.

Read SEC document
February 23, 2026 Filed Feb 25, 2026 00:11 UTC
Eisner MarkEVP and Chief Medical Officer
SaleCommon Stock 2,089 $7.45 $15,568.90
Disclosure

SEC source: 0001628280-26-011329 · wk-form4_1771978287.xml · nonDerivative · entry 2

Eisner Mark · CIK 0001834161 · EVP and Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 157,529

F2 · kind: Represents an automatic and mandatory sale of shares under a Rule 10b5-1 arrangement to satisfy the Issuer's tax withholding obligations in connection with the vesting of RSUs. The sale does not represent a discretionary trade by the Reporting Person.

Read SEC document
February 23, 2026 Filed Feb 25, 2026 00:10 UTC
de Verneuil VaninaEVP, General Counsel, Corp Sec
SaleCommon Stock 4,445 $7.45 $33,127.70
Disclosure

SEC source: 0001628280-26-011328 · wk-form4_1771978240.xml · nonDerivative · entry 2

de Verneuil Vanina · CIK 0002036234 · EVP, General Counsel, Corp Sec

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 129,799

F3 · kind: Represents an automatic and mandatory sale of shares under a Rule 10b5-1 arrangement to satisfy the Issuer's tax withholding obligations in connection with the vesting of RSUs. The sale does not represent a discretionary trade by the Reporting Person.

Read SEC document
February 23, 2026 Filed Feb 25, 2026 00:09 UTC
De Backer MarianneDirector · Chief Executive Officer
SaleCommon Stock 19,039 $7.45 $141,893.86
Disclosure

SEC source: 0001628280-26-011327 · wk-form4_1771978165.xml · nonDerivative · entry 2

De Backer Marianne · CIK 0001797819 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,035,466

F2 · kind: Represents an automatic and mandatory sale of shares under a Rule 10b5-1 arrangement to satisfy the Issuer's tax withholding obligations in connection with the vesting of RSUs. The sale does not represent a discretionary trade by the Reporting Person.

Read SEC document
February 22, 2026 Filed Feb 25, 2026 00:13 UTC
Sabatini BrentSVP, Chief Accounting Officer
GrantStock Option (Right to Buy) · Derivative 50,000 $0.00 Strike: $7.56 $0.00
Disclosure

SEC source: 0001628280-26-011331 · wk-form4_1771978411.xml · derivative · entry 3

Sabatini Brent · CIK 0002037272 · SVP, Chief Accounting Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires 2036-02-21

F3 · derivative.exercise_date: 25% of the shares subject to the stock option will vest and become exercisable on February 22, 2027, and the remaining shares will vest in 36 equal monthly installments thereafter.

Read SEC document
February 22, 2026 Filed Feb 25, 2026 00:13 UTC
Sabatini BrentSVP, Chief Accounting Officer
GrantCommon Stock 25,000 $0.00 $0.00
Disclosure

SEC source: 0001628280-26-011331 · wk-form4_1771978411.xml · nonDerivative · entry 1

Sabatini Brent · CIK 0002037272 · SVP, Chief Accounting Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 72,872

F1 · kind: Acquisition of restricted stock units (RSUs) pursuant to the Issuer's Equity Incentive Plan.

Read SEC document
February 22, 2026 Filed Feb 25, 2026 00:12 UTC
O'Byrne JasonEVP & Chief Financial Officer
GrantStock Option (Right to Buy) · Derivative 110,000 $0.00 Strike: $7.56 $0.00
Disclosure

SEC source: 0001628280-26-011330 · wk-form4_1771978342.xml · derivative · entry 3

O'Byrne Jason · CIK 0001871145 · EVP & Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 110,000

Underlying: Common Stock · 110,000 shares

Expires 2036-02-21

F4 · derivative.exercise_date: 25% of the shares subject to the stock option will vest and become exercisable on February 22, 2027, and the remaining shares will vest in 36 equal monthly installments thereafter.

Read SEC document
February 22, 2026 Filed Feb 25, 2026 00:12 UTC
O'Byrne JasonEVP & Chief Financial Officer
GrantCommon Stock 55,000 $0.00 $0.00
Disclosure

SEC source: 0001628280-26-011330 · wk-form4_1771978342.xml · nonDerivative · entry 1

O'Byrne Jason · CIK 0001871145 · EVP & Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 166,338

F1 · kind: Acquisition of restricted stock units (RSUs) pursuant to the Issuer's Equity Incentive Plan.

F2 · balance_after: Includes 637 shares of common stock acquired by the Reporting Person on November 28, 2025, pursuant to an employee stock purchase program.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.